CD14loCD301b+ macrophages gathering as a proangiogenic marker in adipose tissues.

Abstract

The role of the monocyte marker CD14 in the regulation of obesity is increasingly recognized. Our observations indicated that Cd14^-/- mice exhibited a leaner body shape compared to their wild type (WT) counterparts. And the loss of CD14 alleviated high-fat diet (HFD)-induced obesity in mice. In human subjects, CD14 level was tested to be positively correlated with overweight and obesity. However, the relationship between CD14 and the development of obesity remains only partially understood. To investigate the underlying mechanisms, adipose tissues (AT) from Cd14^-/- and WT mice were subjected to deep RNA sequencing. Gene Ontology enrichment analysis revealed a significant enhancement of angiogenesis-related function in the Cd14^-/- epWAT compared to WT counterpart, which was accompanied by an upregulation of Cd301b. Subsequent assays confirmed the enhanced angiogenesis and more accumulation of CD301b⁺ macrophages in Cd14^-/- epWAT. Because Igf1 expression has been suggested to be associated with Cd301b expression through pseudotime analysis, we found it was IGF-1 secreted from Cd14^-/- macrophages that mediated the angiogenesis enhancement. Collectively, our findings indicate that the accumulation of CD14^loCD301b⁺ macrophages may serve as a proangiogenic marker in adipose tissues, providing novel insights into the relationship between CD14 and obesity development.